文献速递主动脉疾病

Endurant II/IIs联合Heli-FX EndoAnchor腔内缝合动脉瘤修复治疗短颈腹主动脉瘤

Endosuture aneurysm repair in patients treated with Endurant II/IIs in conjunction with Heli-FX EndoAnchor implants for short-neck abdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2019-03-06

ANCHOR注册研究短颈亚组分析纳入70例肾下颈长<10 mm(4-10 mm)的腹主动脉瘤患者,使用Endurant II/IIs支架联合Heli-FX EndoAnchor行腔内缝合动脉瘤修复(ESAR)。技术成功率88.6%,1个月和12个月IA型内漏率低,12个月免于二次介入率95.4%,无支架移位或动脉瘤增大,提示ESAR对短颈AAA安全有效。

要点

  • ESAR在短颈AAA中技术成功率高,IA型内漏和二次介入发生率低。
  • 尽管解剖复杂,ESAR手术时间和透视时间较短,平均植入5.5个EndoAnchor。
  • 12个月内无支架主体移位、动脉瘤直径增大或破裂,但需长期随访验证。

核心结论

  • Endurant II/IIs联合Heli-FX EndoAnchor行ESAR治疗短颈AAA安全有效,技术成功率高,IA型内漏和二次介入发生率低。

研究设计与样本

  • ANCHOR全球注册研究的亚组分析,纳入70例肾下颈长<10 mm(低至4 mm,核心实验室测量)的短颈AAA患者。

主要发现

  • 平均颈长6.9±1.6 mm,平均颈直径25.7±4.0 mm。
  • 研究者报告总体手术成功率97.1%,技术成功率88.6%。
  • 植入手术时间148.0±80.0分钟,EndoAnchor植入时间17.1±11.5分钟,总透视时间35.3±22.0分钟,平均每例植入5.5±2.1个EndoAnchor。
  • 30天内4例报告IA型内漏,其中3例在12个月随访时自发消退;至12个月随访另新增1例IA型内漏,未导致AAA增大或需二次手术。
  • 365天免于二次血管内介入的Kaplan-Meier估计值为95.4%,全因死亡率为92.7%;12个月内无支架主体移位、最大动脉瘤直径增大、动脉瘤破裂或转为开放手术。

临床怎么用

  • 对于肾下颈长<10 mm(低至4 mm)的短颈AAA,ESAR可作为现成的血管内治疗选择。
  • ESAR可作为复杂AAA解剖的补充疗法,但需重视长期随访。

局限性

  • 短期随访结果,长期疗效需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular repair of abdominal aortic aneurysm (AAA) remains a challenging clinical scenario when there is a short or nonexistent segment of healthy infrarenal aorta. This study sought to determine the safety and effectiveness of endosuture aneurysm repair (ESAR) using the Endurant II/IIs endograft (Medtronic Vascular, Santa Rosa, Calif) in conjunction with Heli-FX EndoAnchors (Medtronic Vascular) in the treatment of short-neck AAA. METHODS: In this subgroup analysis, 70 patients were identified from the Aneurysm Treatment Using the Heli-FX EndoAnchor System Global Registry (ANCHOR) who had an infrarenal neck length <10 mm down to 4 mm based on core laboratory measurements. Primary outcomes included technical success of the index procedure, rate of type IA endoleak at 1 month and 12 months, and rate of secondary procedures at 12 months. RESULTS: In this short-neck cohort (n = 70), the average neck length and diameter were 6.9 ± 1.6 mm and 25.7 ± 4.0 mm, respectively. Investigators reported an overall procedural success rate of 97.1% and a technical success rate of 88.6%. The duration of the implant procedure, EndoAnchor implantation, and total fluoroscopy time was 148.0 ± 80.0 minutes, 17.1 ± 11.5 minutes, and 35.3 ± 22.0 minutes, respectively, and an average of 5.5 ± 2.1 EndoAnchors were implanted per patient. Through the 30-day follow-up, type IA endoleaks were reported in four patients, of which three resolved spontaneously by the 12-month follow-up. There was an additional type IA endoleak through the 12-month follow-up that has not resulted in AAA enlargement or required a secondary procedure. The Kaplan-Meier estimate for freedom from secondary endovascular procedures and all-cause mortality is 95.4% and 92.7% through 365 days, respectively. No patient in the short-neck cohort experienced main body stent migration, increase in maximum aneurysm diameter, or aneurysm rupture or required conversion to open surgical repair through 12 months. CONCLUSIONS: In this analysis of the short-neck cohort from ANCHOR, the Endurant II/IIs endograft in conjunction with Heli-FX EndoAnchor implants (ESAR) appears to be a safe and effective treatment option with a high technical success rate and low incidence of type IA endoleaks and secondary interventions. Despite the complex and hostile anatomies, the ESAR method required short procedure and fluoroscopy times. These short-term outcomes suggest that ESAR could be complementary to therapies currently available for treatment of hostile AAA anatomy and a viable off-the-shelf endovascular treatment option for patients with short-neck AAAs, although long-term follow-up is critically important.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Arko FR, Stanley GA, Pearce BJ, et al. Endosuture aneurysm repair in patients treated with Endurant II/IIs in conjunction with Heli-FX EndoAnchor implants for short-neck abdominal aortic aneurysm. J Vasc Surg. 2019. PMID: 30850297. doi:10.1016/j.jvs.2018.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。